B

BioVectra Inc.

387 employees

BioVectra offers contract development and manufacturing capacity for intermediates and active pharmaceutical ingredients.

Basic info

Industry

biotechnology

Sectors

Biotechnology
DMF Regulations and Filings
Speciality Processing Reagents
Biomass extration and Purification
mPEG Reagents
Health Care
GMP Fermentation
Therapeutics
APIs
GMP Custom Chemical Synthesis
Manufacturing
Cytotoxic Handling Capabilites

Date founded

1970

Funding rounds raised

Total raised

$40M

from 1 investors over 1 rounds

B

BioVectra Inc. raised $40M on November 18, 2021

Investors: Government of Canada (2 projects)

FAQ